Formulation having controlled, delayed release of active ingredient

US10874615B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Finn BAUER · Bensheim, DE
• Thorsten Wedel · Riedstadt, DE
• Guenter Moddelmog · Reinheim, DE
• Gudrun BIRK · Darmstadt, DE
• Roberto Ognibene · Arenzano, IT
• Dieter Lubda · Bensheim, DE

Key dates

• Filing date: Aug 25, 2016
• Grant date: Dec 29, 2020
• Expiry date: Aug 25, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P11/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.